Am. Gabilondo et al., MUTATIONS OF TYR(326) IN THE BETA(2)-ADRENOCEPTOR DISRUPT MULTIPLE RECEPTOR FUNCTIONS, European journal of pharmacology, 307(2), 1996, pp. 243-250
A tyrosine residue at the cytoplasmic end of the seventh transmembrane
helix is conserved in many G-protein-coupled receptors. In the human
beta(2)-adrenoceptor, this tyrosine (Tyr(326)) has been proposed to be
a specific determinant for agonist-induced receptor sequestration. In
order to probe its contribution to the sequestration process we have
replaced this tyrosine by alanine (Y326A) or phenylalanine (Y326F). Wi
ld-type and mutant receptors were stably expressed in Chinese hamster
ovary cells. Agonist-induced sequestration was essentially abolished i
n Y326A receptors and only slightly reduced in Y326F receptors. Howeve
r, cells expressing Y326A receptors displayed a high percentage of int
ernal receptors under basal conditions while cells expressing wild-typ
e receptors did not. In addition, high-affinity agonist binding and th
e ability to activate adenylyl cyclase were markedly reduced in Y326A
receptors and slightly reduced in Y326F receptors. We conclude that Ty
r(326) is required for the functional integrity of the beta(2)-adrenoc
eptor and that it may be involved in multiple agonist-induced effects.